Spinal osteomyelitis and spondylodiscitis (SD) are infections of the vertebral body and disc, respectively, with more than 50% associated withStaphylococcus aureus. Methicillin-resistantS. aureus(MRSA) has become a pathogen of interest in cases of SD due to increasing prevalence. The purpose of this investigation was to characterize the current epidemiological and microbiological landscape in SD cases, in addition to medical and surgical challenges in treating these infections.
The PearlDiver Mariner database was queried for ICD-10 codes to identify cases of SD from 2015 to 2021. The initial cohort was stratified by offending pathogens, including methicillin-sensitiveS. aureus(MSSA) and MRSA. Primary outcome measures included epidemiological trends, demographics, and rates of surgical management. Secondary outcomes included length of hospital stay, rate of reoperation, and complications associated with surgical cases. Multivariable logistic regression was used to control for age, gender, region, and Charlson Comorbidity Index (CCI).
Nine thousand nine hundred eighty-three patients met the inclusion criteria and were retained for this study. Approximately half (45.5%) of SD cases resulting fromS. aureusinfections each year were resistant to beta-lactam antibiotics. The proportion of cases that were managed surgically was 31.02%. Among the cases that involved surgical intervention, 21.83% underwent revision operations within 30 days of the original procedure and 37.29% of cases returned to the operating room within 1 year. Substance abuse, specifically alcohol, tobacco, and drug use, were strong predictors for surgical intervention in cases of SD (all p < 0.001), in addition to obesity (p = 0.002), liver disease (p < 0.001), and valvular disease (p = 0.025). After adjusting for age, gender, region, and CCI, cases of MRSA were more likely to undergo surgical management (OR 1.19, p = 0.003). MRSA SD also exhibited higher rates of reoperation within 6 months (OR 1.29, p = 0.001) and 1 year (OR 1.36, p < 0.001). Surgical cases resulting from MRSA infections also exhibited higher morbidity and significant rates of transfusion (OR 1.47, p = 0.030), acute kidney injury (OR 1.35, p = 0.001), pulmonary embolism (OR 1.44, p = 0.030), pneumonia (OR 1.49, p = 0.002), and urinary tract infection (OR 1.45, p = 0.002) compared with MSSA SD infections.
More than 45% of cases ofS. aureusSD in the US are resistant to beta-lactam antibiotics, presenting obstacles in treatment. Cases of MRSA SD are more likely to be managed surgically and have higher rates of complications and reoperations. Early detection and prompt operative management are imperative to reduce the risk of complications.
Approaching the debate of laminectomy versus fusion for grade 1 lumbar spondylolisthesis, the authors leveraged simulation to show how differences between the fusion groups of landmark randomized control trials (RCTs) led to seemingly divergent conclusions, and they offer insights into the design of future RCTs. Lami = laminectomy alone; SLIP = Spinal Laminectomy versus Instrumented Pedicle Screw. See the article in this issue by Meade et al. (pp 696–704). Reprinted with permission, Cleveland Clinic Foundation ©2023. All rights reserved.
INCLUDE WHEN CITING3月17日在线发表,2023;DOI: 10.3171/2023.2.SPINE221353.
DisclosuresDr. Kuris reported being a consultant for SeaSpine and Spineart. Dr. Daniels reported receiving personal fees from Spineart, Stryker, Medtronic, and Orthofix, and receiving grants from Orthofix and Medtronic outside the submitted work.
BerbariEF,KanjSS,KowalskiTJ,et al.2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults.Clin Infect Dis.2015;61(6):e26–e46.
Jaramillo-de la TorreJJ,BohinskiRJ,KuntzCIV.Vertebral osteomyelitis.Neurosurg Clin N Am.2006;17(3):339–351, vii.
SkafGS,DomlojNT,FehlingsMG,et al.Pyogenic spondylodiscitis: an overview.J Infect Public Health.2010;3(1):5–16.
MylonaE,SamarkosM,KakalouE,FanourgiakisP,SkoutelisA.Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics.Semin Arthritis Rheum.2009;39(1):10–17.
GrammaticoL,BaronS,RuschE,et al.Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003.Epidemiol Infect.2008;136(5):653–660.
IssaK,DieboBG,FaloonM,et al.The epidemiology of vertebral osteomyelitis in the United States from 1998 to 2013.Clin Spine Surg.2018;31(2):E102–E108.
ConanY,LaurentE,BelinY,et al.Large increase of vertebral osteomyelitis in France: a 2010-2019 cross-sectional study.Epidemiol Infect.2021;149:e227.
ParkKH,ChoOH,LeeJH,et al.最优时间的抗生素治疗的患者with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence.Clin Infect Dis.2016;62(10):1262–1269.
KehrerM,PedersenC,JensenTG,HallasJ,LassenAT.Increased short- and long-term mortality among patients with infectious spondylodiscitis compared with a reference population.Spine J.2015;15(6):1233–1240.
KimUJ,BaeJY,KimSE,et al.Comparison of pyogenic postoperative and native vertebral osteomyelitis.Spine J.2019;19(5):880–887.
BreuningerM,YagdiranA,WillingerA,et al.Vertebral osteomyelitis after spine surgery: a disease with distinct characteristics.Spine (Phila Pa 1976).2020;45(20):1426–1434.
ParkKH,ChongYP,KimSH,et al.Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.J Infect.2013;67(6):556–564.
LivorsiDJ,DaverNG,AtmarRL,ShelburneSA,WhiteACJr,MusherDM.Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA.J Infect.2008;57(2):128–131.
Al-NammariSS,LucasJD,LamKS.Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis.Spine (Phila Pa 1976).2007;32(22):2480–2486.
McHenryMC,EasleyKA,LockerGA.Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals.Clin Infect Dis.2002;34(10):1342–1350.
GueradoE,CervánAM.Surgical treatment of spondylodiscitis. An update.Int Orthop.2012;36(2):413–420.
HerrenC,JungN,PishnamazM,BreuningerM,SieweJ,SobottkeR.Spondylodiscitis: diagnosis and treatment options.Dtsch Arztebl Int.2017;114(51-52):875–882.
FantoniM,TrecarichiEM,RossiB,et al.Epidemiological and clinical features of pyogenic spondylodiscitis.Eur Rev Med Pharmacol Sci.2012;16(suppl 2):2–7.
AkiyamaT,ChikudaH,YasunagaH,HoriguchiH,FushimiK,SaitaK.Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database.BMJ Open.2013;3(3):e002412.
ParkKH,ChoOH,JungM,et al.Clinical characteristics and outcomes of hematogenous vertebral osteomyelitis caused by gram-negative bacteria.J Infect.2014;69(1):42–50.
DiekemaDJ,PfallerMA,ShortridgeD,ZervosM,JonesRN.Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program.Open Forum Infect Dis.2019;6(suppl 1):S47–S53.
KavanaghKT.Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses.Antimicrob Resist Infect Control.2019;8(1):103.
KourtisAP,HatfieldK,BaggsJ,et al.Vital Signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States.MMWR Morb Mortal Wkly Rep.2019;68(9):214–219.
Trevejo-NunezG,KollsJK,de WitM.Alcohol use as a risk factor in infections and healing: a clinician’s perspective.Alcohol Res.2015;37(2):177–184.
SkiestDJ,BrownK,CooperTW,Hoffman-RobertsH,MussaHR,ElliottAC.Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.J Infect.2007;54(5):427–434.
ShojiH,UrakawaT,WatanabeK,et al.Clinical features, outcomes, and survival factor in patients with vertebral osteomyelitis infected by methicillin-resistant staphylococci.J Orthop Sci.2016;21(3):282–286.
DrydenM,BaguneidM,EckmannC,et al.Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.Clin Microbiol Infect.2015;21(suppl 2):S27–S32.
GouldIM.Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.Int J Antimicrob Agents.2006;28(5):379–384.
SegretoFA,BeyerGA,GriecoP,et al.Vertebral osteomyelitis: a comparison of associated outcomes in early versus delayed surgical treatment.Int J Spine Surg.2018;12(6):703–712.
InoueS,MoriyamaT,HorinouchiY,et al.Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains.Springerplus.2013;2(1):283.
基于“增大化现实”技术agón-SánchezJ,Lázaro-MartínezJL,Quintana-MarreroY,et al.基于“增大化现实”技术e diabetic foot ulcers complicated by MRSA osteomyelitis associated with worse prognosis? Outcomes of a surgical series.Diabet Med.2009;26(5):552–555.
NickersonEK,SinhaR.Vertebral osteomyelitis in adults: an update.Br Med Bull.2016;117(1):121–138.
BolognesiMP,HabermannEB.Commercial Claims Data Sources: PearlDiver and Individual Payer Databases.J Bone Joint Surg Am.2022;104(suppl 3):15–17.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 904 | 904 | 103 |
Full Text Views | 315 | 315 | 11 |
PDF Downloads | 219 | 219 | 12 |
EPUB Downloads | 0 | 0 | 0 |